{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:40:09Z","timestamp":1750005609310,"version":"3.41.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Combination therapy for toxoplasmosis consists of sulfadiazine, pyrimethamine and leucovorin. Although sulfadiazine can cause hypersensitivity reactions, such as fever, rash and liver dysfunction, there is no consensus on an effective therapy for congenital toxoplasmosis (CTox) without sulfadiazine. We attempted desensitization to sulfadiazine in 2 patients with CTox and sulfadiazine hypersensitivity. Desensitization was achieved for 1 patient.<\/jats:p>","DOI":"10.1097\/inf.0000000000002972","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T20:48:04Z","timestamp":1605214084000},"page":"324-326","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Sulfadiazine Hypersensitivity and Desensitization in Children With Congenital Toxoplasmosis: A Report on Two Cases"],"prefix":"10.1097","volume":"40","author":[{"given":"Kei","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kutsuna","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kato","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Goishi","sequence":"additional","affiliation":[{"name":"Department of Neonatology, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Shichino","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jiac.2014.10.013","article-title":"Nationwide survey of mother-to-child infections in Japan.","volume":"21","author":"Yamada","year":"2015","journal-title":"J Infect Chemother"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1128\/CVI.05486-11","article-title":"Anti-toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan.","volume":"19","author":"Sakikawa","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"e20163860","DOI":"10.1542\/peds.2016-3860","article-title":"Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States.","volume":"139","author":"Maldonado","year":"2017","journal-title":"Paediatrics"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0091-6749(91)90311-B","article-title":"Management of sulfadiazine allergy in patients with acquired immunodeficiency syndrome.","volume":"88","author":"de la Hoz Caballer","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.inf.0000202070.59190.9a","article-title":"Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.","volume":"25","author":"McLeod","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(85)91930-0","article-title":"Sulphadiazine desensitisation in AIDS patients.","volume":"1","author":"Bell","year":"1985","journal-title":"Lancet"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00002030-199103000-00011","article-title":"Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis.","volume":"5","author":"Tenant-Flowers","year":"1991","journal-title":"AIDS"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00006454-199605000-00015","article-title":"Rapid oral desensitisation to trimethoprim-sulfamethoxazole in infants and children.","volume":"15","author":"Palusci","year":"1996","journal-title":"Paediatr Infect Dis J"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"CR296","DOI":"10.12659\/MSM.882735","article-title":"Azithromycin versus sulfadiazine and pyrimethamine for non-vision-threatening toxoplasmic retinochoroiditis: a pilot study.","volume":"18","author":"Balaskas","year":"2012","journal-title":"Med Sci Monit"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/jp.2014.161","article-title":"Spiramycin\/cotrimoxazole versus pyrimethamine\/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.","volume":"35","author":"Valentini","year":"2015","journal-title":"J Perinatol"},{"key":"R11-20250615","first-page":"193","article-title":"Congenital toxoplasmosis treatment.","volume":"15","author":"Serranti","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R12-20250615","first-page":"23","article-title":"Follow up of 16 cases with congenital toxoplasmosis treated with azithromycin.","volume":"42","author":"Chen","year":"2004","journal-title":"Zhonghua Er Ke Za Zhi"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:04:21Z","timestamp":1750003461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002972","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2020,11,11]]}}}